Form 4: SeaStar Medical Director Acquires 8,000 Restricted Stock Units

Director Jennifer A. Baird acquired 8,000 restricted stock units in SeaStar Medical Holding Corp on November 13, 2024.

Summary

• Jennifer A. Baird, a director at SeaStar Medical Holding Corp, acquired 8,000 restricted stock units (RSUs) on November 13, 2024.
• Each RSU represents the right to receive one share of SeaStar Medical's common stock.
• The RSUs will vest in equal installments over three years, starting on the first anniversary of June 4, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard insider transaction, which is generally viewed neutrally to slightly positive as it indicates director alignment with company performance.

Positives

• The acquisition of RSUs by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The vesting of the RSUs over the next three years will increase the director's stake in the company.

Industry Context

This is a standard practice for compensating directors and aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across the industry to incentivize performance and align interests with shareholders.
• The vesting schedule of three years is also a typical timeframe for such grants.
• Many companies in the biotech and medical device sectors use similar equity-based compensation plans.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's long-term success.

Next Steps

• The RSUs will vest in three equal annual installments starting June 4, 2025.

Key Dates

Keywords

SeaStar Medical, Restricted Stock Units, RSU, Director, Insider Trading, Beneficial Ownership, Equity Compensation